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Summary
It is widely believed that, if a genetic marker shows a
transmission distortion in patients by the transmission/
disequilibrium test (TDT), then a transmission distor-
tion in healthy siblings would be seen in the opposite
direction. This is also the case in a complex disease.
Furthermore, it has been suggested that replacing the
McNemar statistics of the TDT with a test of hetero-
geneity between transmissions to affected and unaffected
children could increase the power to detect disease as-
sociation. To test these two hypotheses empirically, we
analyzed the transmission of HLA-DQA1-DQB1 hap-
lotypes in 526 Norwegian families with type 1 diabetic
children and healthy siblings, since some DQA1-DQB1
haplotypes represent major genetic risk factors for type
1 diabetes. Despite the strong positive and negative dis-
ease associations with particular DQ haplotypes, we ob-
served no significant deviation from 50% for transmis-
sion to healthy siblings. This could be explained by the
low penetrance of susceptibility alleles, together with the
fact that IDDM loci also harbor strongly protective al-
leles that can override the risk contributed by other loci.
Our results suggest that, in genetically complex diseases,
detectable distortion in transmission to healthy siblings
should not be expected. Furthermore, the original TDT
seems more powerful than a heterogeneity test.
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Family-based association tests have become popular for
identification of genes involved in complex diseases, be-
cause associations due to population stratification are
avoided. These tests also have the potential for discovery
of associations in cases of tight linkage, when linkage
itself is hard to detect (Spielman et al. 1993). It is there-
fore generally believed that association studies of fam-
ilies will become important in the genomewide mapping
of disease genes (Risch and Merikangas 1996).
The most widely applied family-based association test
is probably the transmission/disequilibrium test (TDT),
in which trios of parents and proband are used (Spielman
et al. 1993). Occasionally, data on transmissions to un-
affected siblings are also included in this type of study,
but the interpretation of such data varies. Some inves-
tigators have used these data merely to ensure that no
segregation distortion has occurred (Spielman et al.
1993; Copeman et al. 1995; Nistico et al. 1996; Mer-
riman et al. 1997, 1998; Lie et al. 1999). In other studies,
the transmission to probands has been compared with
transmission to healthy siblings, instead of to the ran-
domly expected 50% (Reed et al. 1997; Nakagawa et
al. 1998), where a transmission distortion is anticipated
for unaffected siblings that is in the direction opposite
to that for affected siblings. Boehnke and Langefeld
(1997) have suggested that the McNemar statistics of
TDT could be replaced by a table of heterogeneity,2# 2
to increase the power to detect disease-involved genes.
Thus, for a disease-associated marker, it is not only
widely expected but also theoretically logical that trans-
mission to healthy siblings would show a trend opposite
to that for transmission to probands.
Type 1 diabetes (MIM 142857) is a complex disease
for which much effort has been devoted to identifying
the predisposing genes. A large number of genomic
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Table 1
TDT of DQA1-DQB1 Haplotypes in Probands or Healthy Siblings in 526 Norwegian
Families with Type 1 Diabetes
HAPLOTYPE
DQA1-DQB1
PROBANDS HEALTHY SIBLINGS
HETEROGENEITY
x2 bNo. (%) T NT x2 a No. (%) T NT x2 a
0301–0302 342 (84) 65 189 261 (49) 271 0 123
0501–0201 247 (76) 78 88 174 (43) 228 7.3 78
0301–0303 15 (54) 13 .1 13 (36) 23 2.7 2
0102–0502 3 (50) 3 0 2 (40) 3 .2 .1
0401–0402 33 (49) 34 0 43 (51) 40 .1 .1
0102–0604 32 (44) 40 .9 43 (55) 35 .8 1.8
0101–0501 47 (29) 115 29 110 (52) 101 .4 20
0301–0301 16 (25) 48 16 38 (49) 39 0 8.8
0201–0201 15 (21) 56 23 41 (51) 40 0 14
0103–0603 12 (14) 74 45 65 (59) 45 3.6 41
0501–0301 7 (13) 47 30 32 (53) 28 .3 21
0201–0303 2 (8) 22 17 14 (47) 16 .1 9.4
0101–0503 0 (0) 12 12 8 (67) 4 1 12
0102–0602 0 (0) 164 164 123 (57) 94 3.9 137
a provides a corrected .2x 1 8.5 P ! .05
b Heterogeneity between affected and unaffected offsprings was tested by 2 x 2 contingency
tables. provides a corrected .2x 1 8.5 P ! .05
regions have been suggested to contribute to the path-
ogenesis (Delepine et al. 1997; Denny et al. 1997; Reed
et al. 1997). That environmental factors trigger the dis-
ease has been implicated by the low penetrance of the
disease (Todd 1991). The major disease locus, IDDM1,
comprises the HLA complex and contributes most
(∼50%) to the familial clustering observed in type 1
diabetes (Davies et al. 1994). However, a number of
minor disease loci (IDDM2–IDDM13, and IDDM15)
have also been assigned (partly reviewed in a study by
Todd [1997]) and later been supplemented by others
(Davies et al. 1994; Merriman et al. 1997). Some fine-
mapping studies of these minor loci presented TDT data
on both affected and unaffected siblings. The transmis-
sions to unaffected siblings showed trends the same or
opposite to that observed for probands, but a deviation
significantly different from 50% was only rarely ob-
served (Spielman et al. 1993; Copeman et al. 1995; Nis-
tico et al. 1996; Merriman et al. 1997, 1998; Reed et
al. 1997; Nakagawa et al. 1998).
We wanted to investigate empirically the behavior of
parental transmission of disease-associated genetic fac-
tors to healthy siblings. Some HLA-DQA1-DQB1 hap-
lotypes represent the most pronounced genetic risk fac-
tors known (She 1996) and should therefore possess the
highest potential to detect an opposite trend. Therefore,
we studied the transmission of DQ haplotypes in families
with type 1 diabetes, using data from 526 Norwegian
families with one affected child (and 12 families with
two affected children), their parents, and unaffected sib-
lings (0–12 sibs in each family) (Undlien et al. 1995a).
The transmissions of DQ haplotypes, both to probands
and to unaffected children, were analyzed by the ex-
tended TDT (ETDT) (Sham and Curtis 1995). The over-
all ETDT statistics for distortion in transmission to pro-
bands provides (13 df; ), whereas2x = 527 P !! .00001
for transmission to healthy siblings (13 df;2x = 22 P =
) is obtained..06
The TDT analyses of individual DQ haplotypes re-
quires in order for statistical significance (2x 1 8.5 P !
) to be obtained after correction for multiple tests..05
As can be seen in table 1, all degrees of associations with
type 1 diabetes were observed for the DQ haplotypes,
in a range of predisposing ( ) to protectiveT 1 50%
( ). As expected, a strong positive associationT ! 50%
was observed for DQA1*0301-DQB1*0302 ( )T = 84%
and DQA1*0501-DQB1*0201 ( ), whereas aT = 76%
remarkably strong negative association was observed for
DQA1*0102-DQB1*0602 ( ). However, no sig-T = 0%
nificant bias in the transmission to healthy siblings was
observed for any DQ haplotype. Only a slight and in-
significant tendency, in the opposite direction, for the
transmission of the strongly associated DQA1*0301-
DQB1*0302 ( ), DQA1*0501-DQB1*0201T = 48%
( ), DQA1*0102-DQB1*0602 ( ) hap-T = 43% T = 57%
lotypes was detected. Thus, despite the very strong pos-
itive and negative disease associations to particular DQ
haplotypes, no statistically significant deviation from
50% was observed for the transmission to healthy sib-
lings. These observations are in agreement with another
study on transmission of DQ haplotypes in families with
type 1 diabetes (Kawasaki et al. 1998), in which trans-
mission to unaffected offspring was presented.
Several factors, both genetic and environmental,
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are needed to develop the disease. Notably, all genetic
risk factors identified to date (e.g., the DRB1*03-
DQA1*0501-DQB1*0201 and DRB1*04-DQA1*03-
DQB1*0302 haplotypes) are present at high frequen-
cies in the general population. Thus, the low penetrance
of the disease in individuals having these haplotypesmay
explain why no significant distortion in transmission to
healthy offspring was observed. In addition, for both
loci that have been fine mapped to a certain extent
(IDDM1 and IDDM2), some alleles have shown strong
protection in an almost dominant fashion (Bennett et al.
1995; Undlien et al. 1995b; Thorsby 1997), and this
might also be the case for other IDDM loci. One could
hypothesize that many healthy individuals are domi-
nantly protected by one or more IDDM loci and that a
distortion in the transmission at another locus would
therefore be unexpected.
A comparison between the McNemar statistics of the
TDT and the heterogeneity test (which compares trans-
mission to probands and unaffected siblings) indicates
that the former provides greater power (table 1). There-
fore, little may be gained by replacing the original TDT
with a heterogeneity test, even though the transmission
to healthy siblings shows the opposite trend. The inclu-
sion of unaffected children may increase the rate of mis-
classified individuals, since this classification is true only
at the time of sample collection. The healthy siblings
may actually introduce more random noise into the data
set, rather than additional information. Hence, the em-
pirical data presented here do not support the advice to
abandon the original TDT and, instead, test the heter-
ogeneity of transmission between affected and unaf-
fected offspring.
In conclusion, our data, together with those from
other studies, suggest that, in genetically complex dis-
eases such as type 1 diabetes, it will be hard to detect
distortion in transmission to healthy siblings, even
though, theoretically, one might expect a transmission
pattern opposite to that observed in probands.
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